N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine
C28H42N8O — CID 117085150
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine
N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine (PubChem CID 117085150) has the molecular formula C28H42N8O and a molecular weight of 506.70 g/mol. Its IUPAC name is N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine.
Molecular Properties
| Compound Name | N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine |
|---|---|
| PubChem CID | 117085150 |
| Molecular Formula | C28H42N8O |
| Molecular Weight | 506.70 g/mol |
| Exact Mass | 506.35 |
| IUPAC Name | N-[2-(4-morpholin-4-ylpiperidin-1-yl)-9-phenylpurin-6-yl]-N',N'-di(propan-2-yl)ethane-1,2-diamine |
| SMILES | CC(C)N(CCNc1nc(N2CCC(N3CCOCC3)CC2)nc2c1ncn2-c1ccccc1)C(C)C |
| InChI | InChI=1S/C28H42N8O/c1-21(2)35(22(3)4)15-12-29-26-25-27(36(20-30-25)24-8-6-5-7-9-24)32-28(31-26)34-13-10-23(11-14-34)33-16-18-37-19-17-33/h5-9,20-23H,10-19H2,1-4H3,(H,29,31,32) |
| InChIKey | YKVWLANQVXKNIZ-UHFFFAOYSA-N |
| XLogP | 3.65 |
| TPSA | 74.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.70 |
| LogP ≤ 5 | 3.65 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117085150 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.